Health
U.K. says study supports delaying 2nd COVID-19 vaccine dose – Los Angeles Times
A study finds that the AstraZeneca-Oxford University vaccine cut coronavirus transmission by two-thirds and prevented COVID-19.
Britains health chief has hailed a new study suggesting that a single dose of the Oxford-AstraZeneca COVID-19 vaccine provides a high level of protection for 12 weeks, saying it supports the governments contentious strategy of delaying the second shot so it can protect more people quickly with a first dose.
Britains decision has been criticized as risky by other European countries, but Health Secretary Matt Hancock said Wednesday that the study backs the strategy that weve taken, and it shows the…
-
Business20 hours agoWhat Warren Buffett’s farewell letter means for Berkshire Hathaway investors
-
General20 hours agoEnvironment Bill passes Senate as Greens cut deal with Labor
-
General19 hours agoCalls for states to change alcohol laws ahead of women’s ministers meeting
-
General4 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire